Testing effectiveness (Phase 2)UnknownNCT02052128
What this trial is testing
Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers
Who this might be right for
Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy
Arno Therapeutics 60